Synexus Polska Sp. z o.o.

The medical center is at the forefront of research in chronic neuropathic pain, focusing on innovative treatments for conditions such as postherpetic neuralgia and pain following peripheral nerve injury. The center's work aims to establish the efficacy of novel therapeutic agents, providing relief to patients suffering from moderate to severe pain.

• Postherpetic Neuralgia
• Peripheral Nerve Injury
• Average Daily Pain Intensity Reduction

Through rigorous clinical trials, the center is dedicated to demonstrating the superiority of new treatments over traditional placebo methods, enhancing patient outcomes in neuropathic pain management.

Specializing in dermatology, the center conducts pivotal research on atopic dermatitis, particularly in adults with moderate to severe conditions. The focus is on evaluating the efficacy of subcutaneous methotrexate, aiming to achieve significant improvements in skin condition and quality of life for patients.

• Atopic Dermatitis
• Eczema Area and Severity Index (EASI)
• Subcutaneous methotrexate

The center's research contributes to the development of effective treatment protocols, offering hope for improved management of chronic skin conditions.

In the field of osteoporosis, the center is pioneering research on post-menopausal bone health. By investigating the therapeutic equivalence of new treatments like BP16, the center aims to enhance bone mineral density and reduce fracture risk in affected populations.

• Post-Menopausal Osteoporosis
• Bone Mineral Density (BMD)
• Serum C-telopeptide (sCTX)

Through comprehensive studies, the center is committed to advancing the understanding and treatment of osteoporosis, promoting better health outcomes for post-menopausal women.